Wine Institute Responds to Administration’s Latest Trade Action and Ongoing Canadian Ban
Today, Wine Institute released the following statement from President and CEO Robert P. Koch in response to the administration’s announcement of new reciprocal tariffs affecting numerous trade partners, including those involved in the import and export of wine with the United States.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407422670/en/
“This isn’t just about trade. It’s about people, livelihoods and an agricultural success story built over generations. When our industry is disrupted, the impact reaches far beyond the winery...” - Robert P. Koch, President & CEO, Wine Institute
Wineries across the country continue to suffer economic harm from Canada’s total ban on U.S. wine sales. Since early March, wine, beer and spirits have been the only U.S. products completely barred from entering and being sold in the Canadian market. Prior to these actions, Canada accounted for 35% of all U.S. wine exports, with a retail value of more than $1.1 billion.
“The wine sector brings people together, drives economic value and reflects the hard work and heritage of families and farmers across the country.
“Today’s announcement of new tariffs will only make it harder for American wineries to regain access to Canada, by far our most important export market. In early March, Canada cleared its shelves of all U.S. wine and continues to block its sale. As this dispute drags on, it is creating economic instability at a time when the industry is already under significant pressure.
“This isn’t just about trade. It’s about people, livelihoods and an agricultural success story built over generations. When our industry is disrupted, the impact reaches far beyond the winery — affecting farmworkers, distributors, small businesses, restaurants and entire communities across the country.”
The U.S. wine industry has long maintained that wine, unlike manufactured goods, is a unique agricultural product and should not be targeted in trade disputes unrelated to the sector. Wine Institute continues to strongly advocate for the removal of wine from all trade retaliation lists, regardless of the market. Retaliatory tariffs not only harm U.S. wine producers but also stall growth and innovation across the entire wine sector.
About Wine Institute
Established in 1934, Wine Institute is the public policy advocacy group of more than 1,000 California wineries and affiliated businesses that initiates and advocates state, federal and international public policy to enhance the environment for the responsible production, consumption and enjoyment of wine.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407422670/en/
Contacts
Media Contact:
Gino DiCaro, 916-730-3443
gdicaro@wineinstitute.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Intelsat Installs Multi-Orbit System on 130 Aircraft, Nearing 1000 Orders8.4.2025 10:00:00 EEST | Press release
Intelsat, operator of the world’s largest integrated satellite and terrestrial networks and leading provider of in-flight connectivity (IFC), installed its pioneering multi-orbit electronically steered array (ESA) system on 130 aircraft, delivering reliable, streaming connectivity to passengers aboard flights throughout North America. Intelsat has secured commitments for 1000 aircraft set to be equipped with the cutting-edge and operational multi-orbit solution. “This milestone underlines the fact that many airlines around the world are gravitating towards multi-orbit inflight connectivity solutions,” said Mike DeMarco, Chief Commercial Officer for Intelsat. “Passengers are already enjoying reliably fast service, based on our airline partners’ satisfaction scores, and we are excited to play a role in their success.” The successful launch of Intelsat's state-of-the-art multi-orbit system represents a major leap forward for in-flight connectivity technology, offering passengers unprecede
DATROWAY ® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer8.4.2025 09:30:00 EEST | Press release
DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medical Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast01 phase 3 trial. In TROPION-Breast01, DATROWAY significantly reduced the risk of disease progression or death by 37% compared to investigator’s choice of chemotherapy (hazard ratio [HR]=0.63; 95% confidence interval [CI]: 0.52-0
Bona Releases 2024 Sustainability Report8.4.2025 09:05:00 EEST | Press release
Bona, a global, family-owned company that supplies products for installing, renovating, maintaining, and restoring premium floors, has published its 2024 Sustainability Report. The report underscores Bona’s resilience in navigating a year of global challenges while advancing key sustainability initiatives. "Throughout 2024 Bona remained steadfast and resilient. Our commitment to sustainability has been a core driver of our innovation, helping us progress toward our environmental, social, and governance goals," said Kerstin Lindell, interim CEO and Chair of the Board, Bona. "We are proud to share the progress we’ve made in reducing our environmental impact, improving working conditions, and fostering greater transparency across our operations." Key Highlights from the 2024 Sustainability Report 41% Reduction in Greenhouse Gas (GHG) Emissions: Bona achieved a significant reduction in GHG emissions (Scope 1 and 2) compared to 2023, driven by renewable energy certificates in North America
POLYVANTIS Flies High at Aircraft Interiors Expo 2025 With Breakthrough Material Solutions That Meet Critical Industry Needs8.4.2025 09:00:00 EEST | Press release
POLYVANTIS, a leading multi-material sheet and film solutions supplier, will present its comprehensive product portfolio for aircraft interiors and glazing solutions at the Aircraft Interiors Expo. POLYVANTIS offers a wide range of films, sheets, and semi-finished products made from polymethyl methacrylate (PMMA), polyphenylsulfone (PPSU), polyetherimide (PEI), and polycarbonate (PC) that meet the high demands placed on materials for the aviation industry. POLYVANTIS serves its global customer base with the renowned brands EUROPLEX®, LEXAN™ PC film and sheet, and PLEXIGLAS® PMMA semi-finished products under one roof. “For decades, customers have relied on our brands for innovative material technologies, applications, and manufacturing processes to support the aircraft interiors industry,” said Peter Chedd, Director, Mass Transportation, Europe at POLYVANTIS. “We are proud to leverage our robust history and introduce our combined expertise as POLYVANTIS. Through products like ULTEM™ she
4Moving Biotech Secures €7.6M France 2030 Grant for Pioneering First-In-Class Disease-Modifying Osteoarthritis Drug8.4.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma developing the first potential disease-modifying drug (DMOAD) for knee osteoarthritis, announces that it has been awarded €7.6 million in funding under the France 2030 plan to accelerate the clinical development of its lead candidate, 4P004, currently in a Phase 2a trial. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407335930/en/ France 2030 is a highly selective and strategic initiative by the French government designed to fast-track the next generation of breakthrough innovations. 4MB's selection is a significant endorsement, granted through a rigorous, multi-stage evaluation process by leading scientific, clinical, and technological experts. This recognition highlights the robust scientific foundations of the 4P004 program and its potential to deliver a truly transformative therapy for OA's unmet medical need and significant socio-economic impact with over 600 million pe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom